Dissecting the Tumor Microenvironment to Predict Immunotherapy Response in Hepatocellular Cancer

Affiliations

¹ Department of Surgery & Cancer, Imperial College London, Hammersmith Hospital, London, United Kingdom; Department of Biomedical Sciences, Humanitas University, Milan, Italy.
² Department of Surgery & Cancer, Imperial College London, Hammersmith Hospital, London, United Kingdom; Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.

Comment

Antonio D'Alessio et al. Gastroenterology. 2022 Dec.

. 2022 Dec;163(6):1712-1713.

doi: 10.1053/j.gastro.2022.08.024. Epub 2022 Aug 11.

¹ Department of Surgery & Cancer, Imperial College London, Hammersmith Hospital, London, United Kingdom; Department of Biomedical Sciences, Humanitas University, Milan, Italy.
² Department of Surgery & Cancer, Imperial College London, Hammersmith Hospital, London, United Kingdom; Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.

No abstract available

Comment on

Molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinoma.
Zhu AX, Abbas AR, de Galarreta MR, Guan Y, Lu S, Koeppen H, Zhang W, Hsu CH, He AR, Ryoo BY, Yau T, Kaseb AO, Burgoyne AM, Dayyani F, Spahn J, Verret W, Finn RS, Toh HC, Lujambio A, Wang Y. Zhu AX, et al. Nat Med. 2022 Aug;28(8):1599-1611. doi: 10.1038/s41591-022-01868-2. Epub 2022 Jun 23. Nat Med. 2022. PMID: 35739268